These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Anti-tumor necrosis factor-α therapy in uveitis. Cordero-Coma M; Sobrin L Surv Ophthalmol; 2015; 60(6):575-89. PubMed ID: 26164735 [TBL] [Abstract][Full Text] [Related]
10. Infliximab in the treatment of refractory posterior uveitis. Joseph A; Raj D; Dua HS; Powell PT; Lanyon PC; Powell RJ Ophthalmology; 2003 Jul; 110(7):1449-53. PubMed ID: 12867408 [TBL] [Abstract][Full Text] [Related]
11. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625 [TBL] [Abstract][Full Text] [Related]
12. Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up. Ardoin SP; Kredich D; Rabinovich E; Schanberg LE; Jaffe GJ Am J Ophthalmol; 2007 Dec; 144(6):844-849. PubMed ID: 17953940 [TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of children with uveitis treated with infliximab. Tugal-Tutkun I; Ayranci O; Kasapcopur O; Kir N J AAPOS; 2008 Dec; 12(6):611-3. PubMed ID: 18930672 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease. Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Hanami K; Tanaka Y Mod Rheumatol; 2011 Apr; 21(2):184-91. PubMed ID: 21052764 [TBL] [Abstract][Full Text] [Related]
15. Expert opinion on the use of biological therapy in non-infectious uveitis. Touhami S; Diwo E; Sève P; Trad S; Bielefeld P; Sène D; Abad S; Brézin A; Quartier P; Koné Paut I; Weber M; Chiquet C; Errera MH; Sellam J; Cacoub P; Kaplanski G; Kodjikian L; Bodaghi B; Saadoun D Expert Opin Biol Ther; 2019 May; 19(5):477-490. PubMed ID: 30888881 [TBL] [Abstract][Full Text] [Related]
16. Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients. Calvo-Río V; Blanco R; Santos-Gómez M; Rubio-Romero E; Cordero-Coma M; Gallego-Flores A; Veroz R; Torre I; Hernández FF; Atanes A; Loricera J; González-Vela MC; Palmou N; Hernández JL; González-Gay MA Semin Arthritis Rheum; 2016 Aug; 46(1):95-101. PubMed ID: 27060872 [TBL] [Abstract][Full Text] [Related]
17. Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate. Tanaka F; Kawakami A; Iwanaga N; Tamai M; Izumi Y; Aratake K; Arima K; Kamachi M; Nakamura H; Huang M; Ida H; Origuchi T; Eguchi K Intern Med; 2006; 45(5):313-6. PubMed ID: 16596001 [TBL] [Abstract][Full Text] [Related]
18. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients. Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907 [TBL] [Abstract][Full Text] [Related]
19. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects. Tognon S; Graziani G; Marcolongo R Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Murphy CC; Ayliffe WH; Booth A; Makanjuola D; Andrews PA; Jayne D Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]